Tenders/Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient Clonazepam, ATC N03AE01 (OBG) for the period 01.08.2024 - 31.07.2026
Awarded🇩🇪GermanySupplies

Conclusion of a non-exclusive discount agreement according to § 130a Paragraph 8 SGB V for the active ingredient Clonazepam, ATC N03AE01 (OBG) for the period 01.08.2024 - 31.07.2026

Auto-translated from German
Original title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Clonazepam, ATC N03AE01 (OBG) für die Zeit 01.08.2024 - 31.07.2026
DAK-Gesundheit
Published: Sep 1, 2026
Updated: Nov 1, 2026
Source: TED - Tenders Electronic Daily (EU)

About This Opportunity

This is a supplies contract in the health and medical services sector. Located in Germany, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Auto-translated from German
DAK-Gesundheit assumes that this procedure, due to a lack of selection decision and thus the non-discriminatory access possibility for all pharmaceutical companies, does not fall within the scope of cartel procurement law. Regardless, it automatically ends upon the entry into force of the exclusive contract for Clonazepam, ATC N03AE01, as a result of a formal procurement procedure according to the regulations of the 4th part of the GWB with one or more contracting partners. In order to do justice to the diversity of potential contracting partners within the framework of the approval model, every pharmaceutical company is enabled to conclude a framework agreement at any time and under the same conditions during the contract term. The necessary contract documents for this are available for download via the online portal www.dtvp.de/center under the link mentioned in 5.1.11. Prerequisites for the conclusion, or later accession, to the contracts that will initially enter into force on 01.08.2024 is the complete and timely submission of the following documents (available for download under the link mentioned in 5.1.11.) to the department below at DAK-Gesundheit: 1. Offer letter 2. Acceptance of the contractual provisions of DAK-Gesundheit, especially also the specified discounts by submitting the contract signed by name or company stamp by the interested party in the designated place. 3. The completed Annexes 1 and 2 to the contract. The interested party must enter the medicines for the above-mentioned active ingredient here, which are to become the subject of the contract. The documents are to be submitted BY EMAIL to: openhouse@dak.de DAK-Gesundheit Department for Medicines (0038 00) Nagelsweg 27-31 20097 Hamburg Annex 2 must be explicitly sent as an Excel file to the email address openhouse@dak.de. Contracts within the framework of this model and for the above-mentioned active ingredient will be concluded for the first time with effect from 01.08.2024 and will end on 31.07.2026. Interested parties who wish to become contracting partners by this date must submit the above-mentioned documents, which are to be submitted, by the 5th of the preceding month BY EMAIL. The offer must be submitted in text form as an electronic offer BY EMAIL to openhouse@dak.de. Submission of the offer by post is not provided for in this procedure. Please DO NOT submit the offer via the German Procurement Portal. For timely submission, electronic receipt of the complete documents BY EMAIL to the email address openhouse@dak.de is sufficient. Later accessions are possible at any time. In order to be able to join on the 1st or 15th of the following month during the contract term, the above-mentioned documents must be available to DAK-Gesundheit by the 5th of the preceding month, regardless of the desired accession. Here too, timely receipt by email at DAK-G is crucial. Example: The accession desired by the bidder is to take place on 07/15 (following month); the documents would have to be available by 06/05 (preceding month). Note: The publication is made here using the form for open procedures. As already made clear, this is not such a procedure - the notice had to be used for technical reasons, as there is no suitable form for approval procedures.

Data provenance

This notice is sourced from TED - Tenders Electronic Daily (EU) and was originally published on September 1, 2026. Last refreshed 17 days ago. Original language: German. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About DAK-Gesundheit

DAK-Gesundheit has issued 328 procurement notices on BidsFactory, including 145 currently open and 110 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Information & Communication Technology. All notices are published for Germany. Notices are distributed via TED - Tenders Electronic Daily (EU), service.bund.de (Germany), and DÖE Bekanntmachungsservice (Germany). Most recent publication: November 17, 2026.

DAK-Gesundheit: buyer profile, tenders and awards

Frequently asked questions about this tender

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

What is the estimated budget?

The estimated contract value is €1. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Germany. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit TED - Tenders Electronic Daily (EU) to access the full notice, required documents, and submission instructions provided by the contracting authority.

Is this tender still open?

No — the contract has already been awarded to neuraxpharm Arzneimittel GmbH. The award notice is archived on BidsFactory for transparency and market intelligence.

Who is the contracting authority?

This notice was issued by DAK-Gesundheit in Germany. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

Find tenders like this automatically

Premium shows the full details of every tender like this one and alerts you instantly when a new one is published.

See plans

Sectors & Categories

Key Details

Estimated Budget
€1
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
German

Source

ted
TED - Tenders Electronic Daily (EU)
Public Procurement

Contracting Authority

DAK-Gesundheit
🇩🇪Germany